Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics
after cardiac surgery and lead to reduced stay at intensive care unit